Jaguar Health, Inc. Profile Avatar - Palmy Investing

Jaguar Health, Inc.

Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segment…

Biotechnology
US, San Francisco [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Jaguar Health, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of JAGX's Analysis
CIK: 1585608 CUSIP: 47010C607 ISIN: US47010C7065 LEI: - UEI: -
Secondary Listings
JAGX has no secondary listings inside our databases.